Biograph 55 is a startup based in the United States, 1 tracked investor.
Biograph 55 is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Develops a bispecific antibody immunotherapy (lead program B%%-001) that targets a regulatory B-cell (B-reg) population in solid tumors; the program is also being developed to eliminate plasma cells involved in autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.